NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Promoter Vipul Nathalal Parekh Acquires 0.57% Stake in Gem Aromatics via Open Market
Mr. Vipul Nathalal Parekh, a promoter of Gem Aromatics Limited, has increased his stake by acquiring 3,00,000 equity shares through the open market. This transaction, completed on March 04, 2026, represents a 0.57% increase in his total holding. Consequently, his individual stake in the company has risen from 17.64% to 18.21%. Promoter buying from the open market is typically interpreted as a strong signal of confidence in the company's valuation and long-term growth prospects.
முக்கிய அம்சங்கள்
Acquisition of 3,00,000 equity shares (0.57% stake) by promoter Vipul Nathalal Parekh.Transaction executed via open market on March 04, 2026.Promoter's total shareholding increased from 92,16,748 shares (17.64%) to 95,16,748 shares (18.21%).Total paid-up equity capital of the company remains at 5,22,37,138 shares with a face value of Rs. 2 each.
👀 கவனிக்க வேண்டியவை
This insider purchase suggests the promoter believes the current market price is attractive. Investors should view this as a positive indicator of internal confidence while continuing to monitor the company's quarterly performance.
Vipul Nathalal Parekh, a Promoter and Whole-Time Director of Gem Aromatics Limited, has acquired 3,00,000 equity shares of the company through an open market transaction on March 04, 2026. The total value of the acquisition is approximately ₹6.19 Crores, reflecting a significant personal investment. This purchase has increased his individual stake from 17.64% to 18.21%. Such substantial promoter buying is typically interpreted as a strong signal of confidence in the company's long-term value and future prospects.
முக்கிய அம்சங்கள்
Promoter Vipul Nathalal Parekh purchased 3,00,000 equity shares via the open market on March 04, 2026.The total transaction value is approximately ₹6.187 crore, excluding taxes and brokerage.The promoter's individual shareholding increased from 17.64% (92,16,748 shares) to 18.21% (95,16,748 shares).The acquisition was executed on the National Stock Exchange (NSE).This disclosure was made under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015.
👀 கவனிக்க வேண்டியவை
Investors should view this increase in promoter stake as a positive indicator of management's confidence in the company's intrinsic value. It may be worth monitoring the stock for further insider activity or upcoming growth catalysts.
Gem Aromatics Starts New Production at Dahej & Secures $1M Export Orders
Gem Aromatics has commenced commercial production of cooling agents (GEM Cool 5) and Safranal at its Dahej facility through its subsidiary, Krystal Ingredients. The company also secured new export orders totaling USD 1 million from the USA and Europe, signaling a revival in international demand due to easing tariff headwinds. This expansion is part of a larger growth strategy where the company is adding 9,229 MTPA capacity to its existing 6,946 MTPA. Management expects the manufacturing of Catalyst for MEHQ to be completed by Q4FY26, further diversifying the product portfolio.
முக்கிய அம்சங்கள்
Commenced commercial production of GEM Cool 5 and Safranal at the Dahej greenfield facilitySecured new export orders aggregating to USD 1 million from USA and European marketsTotal installed capacity stands at 6,946 MTPA with an additional 9,229 MTPA under expansionManufacturing of Catalyst for MEHQ is on track for completion by Q4FY26Revival in export demand attributed to proposed EU FTA and US tariff reductions
👀 கவனிக்க வேண்டியவை
Investors should monitor the revenue ramp-up from the Dahej facility and the successful commissioning of the remaining 9,229 MTPA capacity. The stock offers growth potential as the company transitions from pilot runs to full-scale commercial operations in high-value specialty chemicals.
Gem Aromatics Schedules Plant Visit for 20+ Institutional Investors at Dahej Facility
Gem Aromatics Limited has announced a plant visit for over 20 institutional investors and analysts on February 24, 2026. The visit will take place at the company's Unit 3 facility in Dahej, Gujarat, from 11:30 AM to 3:30 PM. Notable participants include HDFC Securities, Lucky Investment Managers, and Prabhudas Liladhar. The company intends to use its Q3 & 9MFY26 investor presentation for the interaction, highlighting its operational setup to the investment community.
முக்கிய அம்சங்கள்
Plant visit scheduled for February 24, 2026, at the Dahej, Gujarat manufacturing unit.Over 20 major institutional investors and fund houses confirmed for the site visit.Participating firms include HDFC Securities, SageOne Investments, and Nirmal Bang Securities.Discussions will be based on the existing Q3 and 9MFY26 investor presentation.
👀 கவனிக்க வேண்டியவை
Investors should watch for potential research coverage or updates from the participating institutional firms following the site visit. The significant interest from multiple fund houses suggests a positive outlook on the company's manufacturing capabilities.
Gem Aromatics reported Q3 FY26 consolidated revenue of ₹78.9 crore, with gross margins improving significantly to 23% from 14% in the previous quarter. The company successfully commissioned its Greenfield Dahej facility in December 2025, marking a 3x capacity expansion to 16,000 MTPA. Despite a consolidated net loss of ₹5 crore due to high depreciation from the ₹250 crore capitalized capex, management provided strong guidance. The company aims for ₹1,050-1,100 crore in revenue and 16-18% EBITDA margins by FY28 as it diversifies into high-value phenol and cooling agents.
முக்கிய அம்சங்கள்
Commissioned Greenfield Dahej facility on Dec 11, 2025, increasing total capacity 3x to 16,000 MTPAConsolidated gross margins improved to 23% in Q3 FY26 from 14% in the previous quarterIncurred ₹250 crore of the planned ₹270 crore total capex for the Dahej facility expansionManagement targets revenue of ₹1,050-1,100 crore and EBITDA margins of 16-18% by FY28Reported a consolidated net loss of ₹5 crore for Q3 FY26, primarily due to a ₹8.7 crore non-cash depreciation charge
👀 கவனிக்க வேண்டியவை
Investors should focus on the capacity utilization ramp-up at the Dahej plant and the successful commercialization of phenol derivatives in Q1 FY27. While current profitability is masked by high depreciation, the long-term growth trajectory and diversification away from mint-centric products are positive indicators.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Gem Aromatics reported a consolidated revenue of Rs 78.9 Cr for Q3FY26, a 19% YoY decline attributed to tariff uncertainties and GST-related changes. The company achieved a major milestone by commissioning its greenfield Dahej facility on December 11, 2025, with a total capex of Rs 270 Cr. While consolidated PAT showed a loss of Rs 5 Cr due to a high non-cash depreciation charge of Rs 8.7 Cr post-capitalization, standalone EBITDA margins improved to 9.1%. Management has provided a strong long-term guidance, targeting revenues of Rs 1,050-1,100 Cr and EBITDA margins of 16-18% by FY28.
முக்கிய அம்சங்கள்
Commissioned greenfield Dahej plant with 10,829 MTPA capacity on Dec 11, 2025.Consolidated revenue declined 19% YoY to Rs 78.9 Cr, while standalone EBITDA margin rose to 9.1%.Reported consolidated loss of Rs 5 Cr driven by Rs 8.7 Cr in non-cash depreciation from new facility.Management targets aggressive growth to Rs 1,050 - 1,100 Cr revenue by FY28.Diversifying into high-value cooling agents and phenol derivatives to reduce dependency on mint products.
👀 கவனிக்க வேண்டியவை
Investors should focus on the capacity utilization and ramp-up of the Dahej facility in Q4FY26 as the primary growth driver. While the current bottom line is impacted by depreciation, the transition toward high-margin specialty chemicals and the FY28 guidance suggest significant long-term potential.
Gem Aromatics Q3 Results: Consolidated PAT Slips to Loss of ₹5 Cr on High Capex Depreciation
Gem Aromatics reported a consolidated net loss of ₹5.0 crore for Q3 FY26, a sharp decline from a ₹7.5 crore profit YoY, primarily due to ₹8.7 crore in depreciation following the capitalization of its new Dahej facility. Consolidated revenue fell 18.5% YoY to ₹78.9 crore, impacted by external headwinds like GST changes and tariff uncertainties that led to customer inventory optimization. Despite the short-term bottom-line pressure, the company successfully commenced commercial production at its ₹270 crore Dahej plant in December 2025. Management has issued a long-term guidance targeting revenue of ₹1,050-1,100 crore by FY28.
முக்கிய அம்சங்கள்
Consolidated Q3 revenue declined 18.5% YoY to ₹78.9 crore, while 9MFY26 PAT plummeted to ₹0.4 crore from ₹25.8 crore YoY.Reported a consolidated net loss of ₹5.0 crore in Q3 FY26, heavily impacted by ₹8.7 crore in non-cash depreciation charges.Capitalized ₹250 crore of the total ₹270 crore capex for the Dahej facility, which will increase total capacity to approximately 16,000 MTPA.Commenced commercial production of cooling agents (WS-23, WS-03) and clove derivatives at the Dahej plant on December 11, 2025.Management targets FY28 revenue of ₹1,050-1,100 crore with EBITDA margins of 16-18% as asset utilization improves.
👀 கவனிக்க வேண்டியவை
The current net loss is primarily an accounting impact from high depreciation of a major new facility; investors should monitor the ramp-up in capacity utilization at Dahej. The long-term investment case depends on the company's successful transition into high-value specialty chemicals and meeting its ambitious FY28 revenue targets.
Gem Aromatics Q3 Standalone PAT Drops 72% YoY to ₹41.28 Million; Revenue Declines
Gem Aromatics reported a weak set of numbers for the quarter ended December 31, 2025, with standalone revenue from operations falling to ₹839.01 million from ₹891.21 million YoY. Net profit saw a sharp decline of 72% YoY, dropping from ₹148.41 million to ₹41.28 million. In a notable move, the Executive Directors have waived their remuneration for FY 2025-26, citing a challenging business environment and poor financial performance. The company has fully utilized its IPO proceeds of ₹1,628.63 million, primarily for debt repayment.
முக்கிய அம்சங்கள்
Standalone Revenue from operations decreased to ₹839.01 million in Q3 FY26 compared to ₹891.21 million in Q3 FY25.Standalone Net Profit (PAT) plummeted 72% YoY to ₹41.28 million from ₹148.41 million.Earnings Per Share (EPS) fell significantly to ₹0.79 from ₹3.10 in the same quarter last year.Executive Directors waived their entire remuneration for FY 2025-26 due to the current business environment.The company fully utilized ₹1,400 million from IPO proceeds for debt repayment of the company and its subsidiary, Krystal Ingredients.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the sharp decline in both revenue and profitability indicates significant operational headwinds. While the management's salary waiver shows alignment with shareholders, the underlying business performance remains under pressure.
Gem Aromatics Starts Commercial Production of Cooling Agents & Clove Products at Dahej Facility
Gem Aromatics has commenced commercial production of WS-23 and WS-03 cooling agents, clove oil, and eugenol at its new greenfield facility in Dahej, Gujarat. The facility is operated by its wholly-owned subsidiary, Krystal Ingredients Private Limited, and aims to reduce the company's dependence on mint-based products. With a total installed capacity of 5,346 MTPA across three sites, the company serves over 225 domestic and 44 global customers, including major brands like Colgate-Palmolive and Dabur. This expansion into high-value aroma molecules is a strategic move to diversify the product portfolio and improve margins.
முக்கிய அம்சங்கள்
Commencement of commercial production for WS-23 & WS-03 cooling agents and clove-derived products at the Dahej facility.Strategic diversification to reduce reliance on Mint derivatives by expanding into Citral and Phenol derivatives.The company operates with a total installed capacity of 5,346 MTPA across facilities in UP, Gujarat, and Daman & Diu.Serves a global client base across 18 countries, including tier-1 brands like Symrise, Patanjali, and SH Kelkar.The new facility utilizes advanced process technology to deliver high-purity products for oral care, pharma, and cosmetic industries.
👀 கவனிக்க வேண்டியவை
Investors should monitor the revenue contribution and margin improvements resulting from this new facility, as value-added cooling agents typically command higher premiums than traditional mint products.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
